Publications by authors named "Yuji Kaku"

Article Synopsis
  • The HeartMate 3 survival risk score was validated to predict survival chances for patients receiving a HeartMate 3 left ventricular assist device, categorizing them into different survival probability groups.
  • A study involving 181 patients revealed that those in the high survival group had a significantly higher two-year survival rate compared to average and low survival groups, with rates of 93.5%, 81.6%, and 82.0%, respectively.
  • Although the score's original stratification didn't clearly show survival differences, using a binary cutoff indicated better survival for patients in the high-risk category, demonstrating its potential utility in clinical settings.
View Article and Find Full Text PDF
Article Synopsis
  • - The study investigated the effects of two heart preservation methods—ice-cold storage (ICS) and the Paragonix SherpaPak CTS—on ischemia reperfusion injury (IRI) following heart transplantation, as ischemic times have increased since the 2018 allocation system change.
  • - Analysis of biopsies from 90 heart transplant recipients showed similar IRI rates between the two methods, but the CTS group had a significant reduction in coagulative myocyte necrosis (CMN) from weeks 1 to 4, and both methods showed reductions by week 8.
  • - Despite longer ischemic times with CTS, the study found no significant differences in rejection rates or survival between the groups, suggesting that CTS is a viable option
View Article and Find Full Text PDF

Background: Although adverse technical events during aortic root replacement (ARR) are not uncommon and are extremely challenging, there is scant literature to help surgeons prepare for such situations. We describe our experience of outstanding technical events during ARR.

Methods: This is a retrospective study of 830 consecutive ARRs at a single center from 2012 to 2022.

View Article and Find Full Text PDF
Article Synopsis
  • Patients with HeartMate 3 LVADs show improved hemodynamics through pump speed adjustments, particularly during hemodynamic ramp tests conducted from 2015 to 2022.
  • Out of 60 studied patients, only 58% had optimized filling pressures at baseline, but after speed adjustments, 65% achieved optimized measurements.
  • Those who attained optimized pressures experienced significantly lower readmission rates over 6 and 12 months, mainly due to reduced cardiac-related hospitalizations, compared to nonoptimized patients.
View Article and Find Full Text PDF

Background: This study aimed to describe the use of perioperative mechanical circulatory support (MCS) and its impact on outcomes in patients with ischemic cardiomyopathy who were undergoing surgical revascularization.

Methods: Patients with an ejection fraction <35% who underwent isolated coronary artery bypass grafting (CABG) from 2015 to 2021 were identified (N = 378). Patients were divided into no MCS, preoperative MCS, and postoperative MCS groups on the basis of timing of MCS initiation, which included intraaortic balloon pump, extracorporeal membrane oxygenation, or Impella device (Abiomed) use.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to compare 3-year survival rates and readmission rates between patients receiving the HeartMate 3 (HM3) left ventricular assist device (LVAD) and those who underwent orthotopic heart transplantation (OHT) for advanced heart failure.
  • A total of 381 adult patients were analyzed, and after matching based on propensity scores, both groups showed similar 3-year survival rates (83.7% for HM3 vs. 87.0% for OHT) with no significant statistical difference.
  • However, the HM3 group experienced a higher average number of unplanned hospital readmissions over the 3-year period (3.89 for HM3 vs. 2.05 for OHT).
View Article and Find Full Text PDF
Article Synopsis
  • Aortic root thrombosis (ART) is a complication from using the HeartMate 3 (HM3) left ventricular assist device, and this study investigates its incidence and complications.
  • In a cohort of 197 HM3 patients, 9.6% developed ART, and 7.6% experienced moderate or greater aortic insufficiency (AI) over an average follow-up period of 17.5 months.
  • ART was linked to higher risks of severe outcomes, including death, stroke, and the need for aortic valve interventions, emphasizing the importance of monitoring for this complication in HM3 patients.
View Article and Find Full Text PDF
Article Synopsis
  • Aortic regurgitation (AR) is a common issue after left ventricular assist device (LVAD) implantation, specifically in patients with HeartMate 3 (HM3).
  • In a study of 62 stable patients, nearly half had at least mild AR at baseline, but hemodynamic measures did not differ significantly between those with and without AR at the start.
  • While AR did not impact one-year mortality or hospitalization rates, it was associated with increased rates of worsening AR and right ventricular failure over time.
View Article and Find Full Text PDF

Objectives: Tricuspid valve surgery is associated with high rates of shock and in-hospital mortality. Early initiation of venoarterial extracorporeal membrane oxygenation after surgery may provide right ventricular support and improve survival. We evaluated mortality in patients undergoing tricuspid valve surgery based on the timing of venoarterial extracorporeal membrane oxygenation.

View Article and Find Full Text PDF

Background: There are numerous risk-prediction models applied to acute myocardial infarction-related cardiogenic shock (AMI-CS) patients to determine a more accurate prognosis and to assist in patient triage. There is wide heterogeneity among the risk models including the nature of predictors evaluated and their specific outcome measures. The aim of this analysis was to evaluate the performance of 20 risk-prediction models in AMI-CS patients.

View Article and Find Full Text PDF

We applied the Society for Cardiovascular Angiography and Interventions (SCAI) schema to cardiogenic shock (CS) patients treated with venoarterial extracorporeal membrane oxygenation (VA-ECMO) to assess performance in this high acuity group of patients. Records of adult patients receiving VA-ECMO for CS at our institution from 01/2015 to 12/2019 were reviewed. Post-cardiotomy and noncardiogenic shock patients were excluded.

View Article and Find Full Text PDF

Background: Patients requiring femoral venoarterial (VA) extracorporeal life support (ECLS) are at risk of distal lower limb hypoperfusion and ischemia of the cannulated leg. In the present study, we evaluated the effect of using continuous noninvasive lower limb oximetry with near-infrared reflectance spectroscopy (NIRS) to detect tissue hypoxia and guide distal perfusion catheter (DPC) placement on the rates of leg ischemia requiring surgical intervention.

Methods: We performed a retrospective analysis of patients who had undergone femoral VA-ECLS at our institution from 2010 to 2014 (pre-NIRS era) and 2017 to 2021 (NIRS era).

View Article and Find Full Text PDF

Objective: Although extracorporeal life support (ECLS) has increasingly been used for the treatment of patients with cardiogenic shock (CS), the outcomes of those successfully weaned from support remain poorly defined.

Methods: Of 510 venoarterial ECLS CS patients at our institution between January 2015 and December 2020, 249 were decannulated and survived for 30 days or until discharge (ie, successfully weaned). Factors associated with survival to discharge were assessed and 1-year survival was described.

View Article and Find Full Text PDF

Objectives: del Nido cardioplegia is used to pharmacologically arrest the heart during cardiac surgery and decrease reperfusion- and ischaemia-related myocardial injury. Studies have demonstrated the physiological differences between male and female hearts, potentially related to cardiac size or myocyte calcium handling; we aimed to assess for between-sex differences in clinical outcomes after receipt of del Nido cardioplegia.

Methods: Patients who underwent coronary artery bypass or coronary artery bypass graft/valve surgery at our institution using del Nido cardioplegia (January 2014 to December 2019) were included (n = 2118).

View Article and Find Full Text PDF

Background: As cardiac re-transplantation is associated with inferior outcomes compared with primary transplantation, allocating scarce resources to appropriate re-transplant candidates is important. The aim of this study is to elucidate the factors associated with 1-year mortality in cardiac re-transplantation using the random forests algorithm for survival analysis.

Methods: We retrospectively reviewed the United Network for Organ Sharing registry and identified all adult (> 17 years old) recipients who underwent cardiac re-transplantation between January 2000 and March 2020.

View Article and Find Full Text PDF

Stroke has potentially devastating consequences for patients receiving veno-arterial extracorporeal membrane support (VA-ECMO). Arterial cannulation sites for VA-ECMO include the ascending aorta, axillary artery, and femoral artery. However, the influence of cannulation site on stroke risk has not been well described.

View Article and Find Full Text PDF

Objectives: Left atrial appendage occlusion (LAAO) at the time of implantation may reduce thromboembolic events (TEs) during continuous-flow left ventricular assist device support. The HeartMate 3 (HM3) reduces TEs overall, but the efficacy of LAAO in HM3 is unknown.

Methods: Adults receiving first HM3 implantation from November 2014 through December 2019 at a single, large medical centre were retrospectively reviewed.

View Article and Find Full Text PDF

Aims: We aimed to detail the early clinical experience with pVAD 5.5 at a large academic medical centre. Impella® 5.

View Article and Find Full Text PDF

Venoarterial extracorporeal membrane oxygenation (VA ECMO) is used to provide cardiopulmonary support in cardiogenic shock; however, high extracorporeal flow may increase left ventricular (LV) afterload leading to LV distention and intracardiac stasis. It is unclear how ECMO flow affects patient outcomes and complications related to ECMO. Retrospective review of patients at a single institution placed on VA ECMO from 2007 to 2018 was performed.

View Article and Find Full Text PDF

The aim of this study was to evaluate the fluid dynamics in the aortic valve and proximal aorta during continuous-flow left ventricular assist device (LVAD) support using epiaortic echocardiography and vector flow mapping technology. A total of 12 patients who underwent HeartMate 3 implantation between December 2018 and February 2020 were prospectively examined. The wall shear stress (WSS) on the ascending aorta, aortic root, and aortic valve was evaluated before and after LVAD implantation.

View Article and Find Full Text PDF